• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secukinumab treatment of tumor necrosis factor antagonists induced paradoxical psoriasis flares in a patient with plaque psoriasis.

作者信息

Zheng Jianfeng, Li Ying, Ding Yangfeng, Gao Yunlu

机构信息

Department of Dermatology, Shanghai Skin Diseases Hospital, Shanghai, China.

Institute of Psoriasis, Tongji University School of Medicine, Shanghai, China.

出版信息

Dermatol Ther. 2020 Nov;33(6):e14455. doi: 10.1111/dth.14455. Epub 2020 Nov 18.

DOI:10.1111/dth.14455
PMID:33107149
Abstract
摘要

相似文献

1
Secukinumab treatment of tumor necrosis factor antagonists induced paradoxical psoriasis flares in a patient with plaque psoriasis.司库奇尤单抗治疗肿瘤坏死因子拮抗剂诱发的斑块状银屑病患者矛盾性银屑病发作。
Dermatol Ther. 2020 Nov;33(6):e14455. doi: 10.1111/dth.14455. Epub 2020 Nov 18.
2
Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series.司库奇尤单抗可治疗强直性脊柱炎患者中由抗TNF-α治疗引起的银屑病：病例系列。
Int J Rheum Dis. 2020 Mar;23(3):454-456. doi: 10.1111/1756-185X.13791. Epub 2020 Jan 15.
3
Management with secukinumab of tumour necrosis factor inhibitor-induced pulmonary sarcoidosis-like reaction in a patient with psoriasis.用司库奇尤单抗治疗一名银屑病患者肿瘤坏死因子抑制剂诱发的肺结节病样反应
Clin Exp Dermatol. 2020 Jun;45(4):455-456. doi: 10.1111/ced.14101. Epub 2019 Oct 11.
4
Paradoxical psoriasis induced by anti-TNF-alpha successfully treated with brodalumab.
Dermatol Ther. 2021 Sep;34(5):e15084. doi: 10.1111/dth.15084. Epub 2021 Aug 10.
5
Secukinumab-induced palmar vesiculopustular eruption in a patient with psoriasis.司库奇尤单抗诱导的一名银屑病患者手掌部水疱脓疱性皮疹
Dermatol Ther. 2020 May;33(3):e13332. doi: 10.1111/dth.13332. Epub 2020 Apr 7.
6
IL-17A Inhibitor Switching - Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience.白细胞介素 17A 抑制剂转换 - 司库奇尤单抗治疗失败后使用依奇珠单抗的疗效。一项单中心经验。
Acta Derm Venereol. 2019 Jul 1;99(9):769-773. doi: 10.2340/00015555-3200.
7
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.司库奇尤单抗对银屑病患者内皮功能障碍及其他心血管疾病参数的影响：52 周研究结果
J Invest Dermatol. 2019 May;139(5):1054-1062. doi: 10.1016/j.jid.2018.10.042. Epub 2018 Nov 30.
8
Secukinumab-induced scar sarcoidosis in a patient with plaque psoriasis.司库奇尤单抗诱发斑块状银屑病患者出现瘢痕结节病。
Australas J Dermatol. 2022 May;63(2):e187-e189. doi: 10.1111/ajd.13799. Epub 2022 Feb 9.
9
Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative case report.司库奇尤单抗治疗合并多发性硬化症的斑块状银屑病患者：一篇包含典型病例报告的小型综述
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e110-e112. doi: 10.1111/jdv.16035. Epub 2019 Nov 14.
10
Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials.司库奇尤单抗治疗肿瘤坏死因子抑制剂应答不足的活动性类风湿关节炎的疗效和安全性：III 期随机对照临床试验的荟萃分析。
Clin Rheumatol. 2019 Oct;38(10):2765-2776. doi: 10.1007/s10067-019-04595-1. Epub 2019 May 14.